EMG
LNAI

ETF Managers Group’s Lunai Bioworks LNAI Stock Holding History

ETF Managers Group’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-195
Closed -$28K – 661
2022
Q3 		$28K Sell
195
-14
-7% -$2.55K ﹤0.01% 684
2022
Q2 		$40K Buy
209
+9
+5% +$4.12K ﹤0.01% 718
2022
Q1 		$129K Buy
200
+3
+2% +$1.6K ﹤0.01% 622
2021
Q4 		$117K Sell
197
-39
-17% -$28.3K ﹤0.01% 629
2021
Q3 		$126K Buy
236
+60
+34% +$29.3K ﹤0.01% 630
2021
Q2 		$72K Sell
176
-3
-2% -$978 ﹤0.01% 632
2021
Q1 		$47K Sell
179
-105
-37% -$30.9K ﹤0.01% 653
2020
Q4 		$73K Sell
284
-45
-14% -$11.4K ﹤0.01% 604
2020
Q3 		$98K Buy
+329
New +$104K ﹤0.01% 602

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ETF Managers Group's LNAI Position: Q4 2022 in Review

ETF Managers Group sold out of Lunai Bioworks (LNAI) in Q4 2022, closing a stake of 195 shares — an estimated $28K sold.

ETF Managers Group first reported a position in LNAI in Q3 2020 and held it in 9 quarters. The position peaked at $129K in Q1 2022. 36 funds tracked by Wall St. Rank hold LNAI as of Q4 2022.

  • ETF Managers Group reported no remaining Lunai Bioworks position as of Q4 2022 after selling out during the quarter.
  • ETF Managers Group sold 195 Lunai Bioworks shares in Q4 2022, an estimated $28K.
  • ETF Managers Group first reported a position in Lunai Bioworks in Q3 2020 and held it in 9 quarters.
  • ETF Managers Group's Lunai Bioworks position peaked at $129K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2022.

Based on ETF Managers Group's 13F filing for Q4 2022, filed 23 Mar 2023.